1. Assessment of adherence to mesalazine maintenance therapy over 1 year using memscaps monitoring system: a substudy of the coda trial comparing once- versus three times daily asacol in ulcerative colitis (UC). (13th March 2011) Authors: Hawthorne, A B; Stenson, R; Gillespie, D; Kapur, K; Hood, K; Probert, C S Journal: Gut Issue: Volume 60:(2011)Supplement 1 Page Start: A147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Once daily Asacol. (13th March 2011) Authors: Hawthorne, A B; Stenson, R; Gillespie, D; Swarbrick, E T; Dhar, A; Kapur, K C; Hood, K; Probert, C S Journal: Gut Issue: Volume 60:(2011)Supplement 1 Page Start: A37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Safety of the use of gold nanoparticles conjugated with proinsulin peptide and administered by hollow microneedles as an immunotherapy in type 1 diabetes. Issue 1 (27th January 2022) Authors: Tatovic, D; McAteer, M A; Barry, J; Barrientos, A; Rodríguez Terradillos, K; Perera, I; Kochba, E; Levin, Y; Dul, M; Coulman, S A; Birchall, J C; von Ruhland, C; Howell, A; Stenson, R; Alhadj Ali, M; Luzio, S D; Dunseath, G; Cheung, W Y; Holland, G; May, K Journal: Immunotherapy advances Issue: Volume 2:Issue 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗